AXENTIS PHARMA
Axentis Pharma AG is a Swiss-based pharmaceutical company focused on value-added anti-infectives in combination with novel inhalation devices. Following the entrance of a License Agreement with a Japanese partner, Axentis Pharma engaged in the development of AX-TOBRA, a liposome-based drug-device combination to combat chronic lung diseases and respiratory disorders, especially cystic fibrosis. AX-TOBRA received Orphan Designations from EU-EMA and US-FDA.
AXENTIS PHARMA
Industry:
Pharmaceutical
Address:
Zürich, Zurich, Switzerland
Country:
Switzerland
Status:
Closed
Technology used in webpage:
Domain Not Resolving
Current Employees Featured
